WEREWOLF THERAPEUTICS, INC. Deferred Tax Assets, Other
WEREWOLF THERAPEUTICS, INC. (HOWL) had Deferred Tax Assets, Other of $9.47 million as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxAssetsOther · last filed 2023-03-23
- 2022-12-31: Deferred Tax Assets, Other $9.47M.
- 2021-12-31: Deferred Tax Assets, Other $0.00.
| Period end | Deferred Tax Assets, Other |
|---|---|
| 2022-12-31 | $9.47M 10-K · filed 2023-03-23 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |